GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (OTCPK:GRRMY) » Definitions » 3-Year EPS without NRI Growth Rate

Gerresheimer AG (Gerresheimer AG) 3-Year EPS without NRI Growth Rate : 4.60% (As of Feb. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Gerresheimer AG 3-Year EPS without NRI Growth Rate?

Gerresheimer AG's EPS without NRI for the three months ended in Feb. 2024 was $0.10.

During the past 12 months, Gerresheimer AG's average EPS without NRI Growth Rate was 11.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 4.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Gerresheimer AG was 116.80% per year. The lowest was -12.30% per year. And the median was 15.65% per year.


Competitive Comparison of Gerresheimer AG's 3-Year EPS without NRI Growth Rate

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gerresheimer AG's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's 3-Year EPS without NRI Growth Rate falls into.



Gerresheimer AG 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Gerresheimer AG  (OTCPK:GRRMY) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Gerresheimer AG 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Gerresheimer AG (Gerresheimer AG) Business Description

Traded in Other Exchanges
Address
Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.

Gerresheimer AG (Gerresheimer AG) Headlines

From GuruFocus

Gerresheimer Business Model Robust

By PRNewswire PRNewswire 04-09-2020

Gerresheimer With Strong Second Quarter

By PRNewswire PRNewswire 07-14-2020

Gerresheimer Business Model Robust

By PRNewswire PRNewswire 04-09-2020